These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30262728)

  • 21. Role of the K(Ca)3.1 K+ channel in auricular lymph node CD4+ T-lymphocyte function of the delayed-type hypersensitivity model.
    Ohya S; Nakamura E; Horiba S; Kito H; Matsui M; Yamamura H; Imaizumi Y
    Br J Pharmacol; 2013 Jul; 169(5):1011-23. PubMed ID: 23594188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
    Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
    PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.
    Bouhy D; Ghasemlou N; Lively S; Redensek A; Rathore KI; Schlichter LC; David S
    J Neurosci; 2011 Nov; 31(45):16298-308. PubMed ID: 22072681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K
    Pang ZD; Wang Y; Wang XJ; She G; Ma XZ; Song Z; Zhao LM; Wang HF; Lai BC; Gou W; Du XJ; Deng XL
    FASEB J; 2019 Dec; 33(12):14760-14771. PubMed ID: 31690106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
    Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
    Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells.
    Srivastava S; Li Z; Ko K; Choudhury P; Albaqumi M; Johnson AK; Yan Y; Backer JM; Unutmaz D; Coetzee WA; Skolnik EY
    Mol Cell; 2006 Dec; 24(5):665-675. PubMed ID: 17157250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.
    Yi M; Yu P; Lu Q; Geller HM; Yu Z; Chen H
    Mol Cell Neurosci; 2016 Oct; 76():21-32. PubMed ID: 27567685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway.
    Yi M; Dou F; Lu Q; Yu Z; Chen H
    Neurosci Lett; 2016 Jun; 624():62-71. PubMed ID: 27163196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
    Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
    PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible Contribution of Inflammation-Associated Hypoxia to Increased K
    Endo K; Kito H; Tanaka R; Kajikuri J; Tanaka S; Elboray EE; Suzuki T; Ohya S
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockage of K(Ca)3.1 and Kv1.3 channels of the B lymphocyte decreases the inflammatory monocyte chemotaxis.
    Zhang S; Wang X; Ju C; Zhu L; Du Y; Gao C
    Int Immunopharmacol; 2016 Feb; 31():266-71. PubMed ID: 26795234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
    Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
    Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia.
    Ohya S; Niwa S; Kojima Y; Sasaki S; Sakuragi M; Kohri K; Imaizumi Y
    J Pharmacol Exp Ther; 2011 Aug; 338(2):528-36. PubMed ID: 21602424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The class II phosphatidylinositol 3 kinase C2beta is required for the activation of the K+ channel KCa3.1 and CD4 T-cells.
    Srivastava S; Di L; Zhdanova O; Li Z; Vardhana S; Wan Q; Yan Y; Varma R; Backer J; Wulff H; Dustin ML; Skolnik EY
    Mol Biol Cell; 2009 Sep; 20(17):3783-91. PubMed ID: 19587117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.
    Chen YJ; Lam J; Gregory CR; Schrepfer S; Wulff H
    PLoS One; 2013; 8(11):e81006. PubMed ID: 24312257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-gated K
    Tarasov MV; Bystrova MF; Kotova PD; Rogachevskaja OA; Sysoeva VY; Kolesnikov SS
    Pflugers Arch; 2017 Feb; 469(2):349-362. PubMed ID: 28028617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.
    Huang C; Day ML; Poronnik P; Pollock CA; Chen XM
    Int J Biochem Cell Biol; 2014 Feb; 47():1-10. PubMed ID: 24291552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases.
    Felice C; Lewis A; Armuzzi A; Lindsay JO; Silver A
    Aliment Pharmacol Ther; 2015 Jan; 41(1):26-38. PubMed ID: 25367825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
    Vigneault P; Naud P; Qi X; Xiao J; Villeneuve L; Davis DR; Nattel S
    J Physiol; 2018 Jun; 596(12):2359-2379. PubMed ID: 29574723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.